EXPONENTS INC

EXPONENTS INC

New York, NY, US
•
501(c)3
•
EIN
13-3572677
•
EXPONENTS.ORG

EXPONENTS INC

New York, NY, US
•
501(c)3
•
EIN
13-3572677
•
EXPONENTS.ORG
Overview
Programs
990s
Income Statement
Balance Sheet
Sign up for more:
People
Board & Team
Financials
Financial Trends
Funding
Funders
Grants Received
Hide details

Programs

  • Harm Reduction and Recovery Support Services
    TRAINING AND COUNSELING - ENCOMPASSES OUR HARM REDUCTION AND RECOVERY SUPPORT SERVICES INCLUDING ARRIVE A 24 SESSION GROUP INTERVENTION WITH ACCOMPANYING INDIVIDUAL COUNSELING FOR ACTIVE USERS WHO ARE HIV+; OUR RECOVERY AND WELLNESS CENTER WHICH PROVIDES A FULL SCHEDULE OF SUPPORTIVE SERVICES AND SOCIALIZATION ACTIVITIES FOR PARTICIPANTS AT ANY STAGE OF RECOVERY; EVIDENCE BASED INTERVENTIONS INCLUDING SEEKING SAFETY WHICH ENGAGES CLIENTS TO WORK ON EXPERIENCED TRAUMA; AND OUR PREVENTION SERVICES TARGETED THE LGBT COMMUNITY.
    Geographies
    Not indicated
    Dates
    Jul 1, 2021 – Jun 30, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $2M
  • Outpatient Drug Treatment Program
    DRUG TREATMENT PROGRAM - OUR MEDICALLY SUPERVISED, OUTPATIENT DRUG TREATMENT PROGRAM IS LICENSED BY THE STATE TO PROVIDE INTENSIVE AND NON-INTENSIVE SUBSTANCE USE TREATMENT VIA GROUP AND INDIVIDUAL COUNSELING, MEDICATION ASSISTED TREATMENT UTILIZING BUPRENORPHINE AND VIVITROL. OUR PROGRAM EMPLOYS A HARM REDUCTION APPROACH TO ENGAGING ACTIVE USERS. WE PROVIDE AN AVERAGE OF 8,000 SERVICES ANNUALLY.
    Geographies
    Not indicated
    Dates
    Jul 1, 2021 – Jun 30, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $801.6K
  • HIV Testing and Outreach Services
    TESTING & OUTREACH OUR EARLY INTENTIONS AND TESTING SERVICES PROVIDE HIV TESTING AND HEPATITIS C SCREENING AND LINKAGE TO PRIMARY CARE AND OUTREACH AND EDUCATION AROUND PREP AND PEP TREATMENT. HIV TESTING IS PROVIDED ON-SITE AT EXPONENTS, ON OUR MOBILE UNIT AND AT PARTNER AGENCIES AND WE TEST APPROXIMATELY 1440 HIGH RISK INDIVIDUALS ANNUALLY AND SCREEN APPROXIMATELY 600 ANNUALLY FOR HEPATITIS C. OUR OUTREACH SERVICES PROVIDE INFORMATION AND REFERRAL TO OUR DRUG TREATMENT, HARM REDUCTION AND TREATMENT ADHERENCE PROGRAMS INCLUDING PROPHYLACTIC MEDICATION TO PREVENT THE TRANSMISSION OF HIV BETWEEN SERODISCORDANT PARTNERS.
    Geographies
    Not indicated
    Dates
    Jul 1, 2021 – Jun 30, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $625.7K
Programs
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)
Terms of Use
Privacy Policy